Corrigendum: Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (Front. Pediatr., (2020), 8, (372), 10.3389/fped.2020.00372)

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

In the original article, we neglected to include “Co-funded by European Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”” in the Funding Statement. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Cite

CITATION STYLE

APA

García-Robles, A., Gimeno Navarro, A., Serrano Martín, M. del M., Párraga Quiles, M. J., Parra Llorca, A., Poveda-Andrés, J. L., … Aguar Carrascosa, M. (2022, January 13). Corrigendum: Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (Front. Pediatr., (2020), 8, (372), 10.3389/fped.2020.00372). Frontiers in Pediatrics. Frontiers Media S.A. https://doi.org/10.3389/fped.2021.834454

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free